Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WRAPUP 5-Europe enacts new curbs as COVID surges in absence of vaccine

Tue, 27th Oct 2020 10:57

(Adds Spain, EU)

* Anti-restriction protests turn violent in Italy

* France warns of "difficult decisions" ahead

* Trump pushes vaccines, but none yet available

By Crispian Balmer

ROME, Oct 27 (Reuters) - European governments moved on
Tuesday to impose new curbs to try to rein in a fast-growing
surge of coronavirus infections and provide economic balm to
help businesses survive the pandemic.

World leaders face an increasingly difficult task holding
the disease at bay while keeping their economies afloat as they
pin their hopes on as-yet unproven vaccines.

"We are dealing with exponential growth," German Economy
Minister Peter Altmaier told a virtual German-French economic
conference in Berlin. "In Germany the number of new infections
is rising by 70-75% compared to the week before."

The United States, Russia, France, Sweden, Poland and other
countries have registered record numbers of infections in recent
days as autumn turns to winter in the Northern Hemisphere and
people socialise indoors where the risk of infection is higher.

More than 43.4 million people have been infected by the
coronavirus globally and 1,158,056? have died, according to a
Reuters tally, with the United States leading the way in the
number of infections and deaths.

Hundreds of protesters took to the streets across Italy on
Monday to vent their anger at the latest round of restrictions,
including early closing for bars and restaurants, with
demonstrations in some cities turning violent.

In the financial capital Milan, youths hurled petrol bombs
at police, who responded with volleys of tear gas. In nearby
Turin, luxury shops had their windows smashed and some were
ransacked, leading to the arrest of 10 rioters.

In France, Interior Minister Gerald Darmanin warned the
country to prepare for "difficult decisions" after some of the
strictest restrictions currently in place anywhere in Europe
have failed to halt the spread of the disease.

The Czech government will ask lawmakers to extend its
emergency powers until Dec. 3, Prime Minister Andrej Babis said
on Tuesday, as it tries to stem one of the strongest surges in
infections in Europe.

BRAIN FUNCTION AFFECTED

There have been at least 8.54 million reported infections
and 251,000 deaths caused by coronavirus in Europe so far,
according to latest Reuters data. The continent registered a
record 230,892 new cases on Monday, up from 67,739 on Oct. 1.

Authorities in Russia, which with 1.55 million infections
has the world's fourth largest COVID-19 case load, ordered
people to wear facemasks in some public places and asked
regional authorities to consider shutting bars and restaurants
overnight.

New infections in Belgium, among the hardest-hit countries
in Europe, hit a high of more than 18,000 on Oct. 20, almost a
10-fold increase from the high of a spring wave of the pandemic.

The country is expected to decide by this weekend whether a
return to a nationwide lockdown is required.

Even Germany, widely praised for its initial response to the
pandemic, signalled concern on Tuesday over rising infections,
with Altmaier saying the country was likely to reach 20,000
cases a day by the end of this week.

Spain's wine-producing region of La Rioja ordered the
closure of restaurants and bars in its two largest towns for a
month. A nationwide curfew has been in place since Sunday.

A gauge of global stock markets fell and the U.S. dollar
slipped on Tuesday as investors grappled with a surge in
coronavirus cases and uncertainty over the impending U.S.
election.

Adding to the gloomy sentiment, a new study by Imperial
College London found that antibodies against the new coronavirus
declined rapidly in the British population during summer,
suggesting protection after infection may not be long-lasting.
Recovering patients may also suffer a decline in
brain function, researchers warned.

In the United States, the number of hospitalised COVID-19
patients is at a two-month high, straining health care systems
in some states. The U.S. death toll leads the world at more than
225,300.

"Until November 4th., Fake News Media is going full on
Covid, Covid, Covid," President Donald Trump, facing a tough
re-election battle on Nov. 3, tweeted on Tuesday in an
often-repeated refrain without offering evidence. "We are
rounding the turn. 99.9%."

Trump has often promoted vaccines as the answer, but none
has yet won international approval. Russia in August became the
first country to grant regulatory approval for a vaccine after
less than two months of human testing, raising eyebrows among
sceptical scientists in the West.

A vaccine being developed by the University of Oxford and
AstraZeneca Plc produces an immune response in both old
and young adults, the company said on Monday, raising hopes of a
path out of the gloom.

But only a share of the EU population can be inoculated
before 2022, should a vaccine become available, EU officials
said in an internal meeting on Tuesday.

The warning comes in spite of the fact that the 27-nation
bloc, with a population of 450 million, has secured more than a
billion doses of potential vaccines from three drugmakers.

(Reporting by Reuters bureaux; Writing by Crispian Balmer and
Nick Macfie; Editing by Alison Williams and Jon Boyle)

More News
21 May 2024 12:03

CORRECT: Stocks fall but pound up as IMF ups UK forecast

(Correcting London Stock Exchange index prices.)

Read more
21 May 2024 12:00

LONDON MARKET MIDDAY: Stocks fall but pound up as IMF ups UK forecast

(Alliance News) - Stock prices in Europe were lower heading into Tuesday afternoon, with shares in New York also set for a muted open, as a recent rally for equities takes a pause.

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 09:04

LONDON MARKET OPEN: FTSE 100 declines after Asian stocks fall

(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.

Read more
21 May 2024 08:18

TOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aim

(Alliance News) - AstraZeneca PLC on Tuesday set out its ambition to achieve USD80 billion in annual revenue by the end of the decade as it signalled a new "era of growth."

Read more
21 May 2024 07:52

LONDON BRIEFING: AstraZeneca plots "new era of growth"; SSP confident

(Alliance News) - London's FTSE 100 is called to open lower on Tuesday, following a mixed close in New York overnight, and tepid trade in Asia.

Read more
21 May 2024 07:34

AstraZeneca lays out plans to hit $80bn in revenues by 2030

(Sharecast News) - AstraZeneca has unveiled medium-term growth targets to nearly double group revenues by the end of the decade as it predicts significant growth from existing oncology, biopharmaceuticals and rare disease portfolios.

Read more
20 May 2024 11:55

LONDON MARKET MIDDAY: Gold shines amid interest rate cut hopes

(Alliance News) - Stock prices in London got a boost at midday on Monday, as investors eye a key UK inflation reading later in the week, which is expected to show cooling prices.

Read more
20 May 2024 08:56

AstraZeneca to build $1.5-bln cancer drug plant in Singapore

Plans to build ADCs manufacturing facility in Singapore

*

Read more
20 May 2024 08:24

TOP NEWS: AstraZeneca plans to build manufacturing plant in Singapore

(Alliance News) - AstraZeneca PLC on Monday announced plans for a USD1.5 billion manufacturing facility in Singapore to produce antibody drug conjugates, treatments that deliver "highly potent cancer-killing agents".

Read more
20 May 2024 07:47

LONDON BRIEFING: Keywords would back GBP2.0 billion bid as EQT circles

(Alliance News) - London's FTSE 100 is called to open higher at the start of the week, while the pound climbed and gold hit another record high, with investors hopeful the Federal Reserve could soon cut US interest rates.

Read more
20 May 2024 07:22

AstraZeneca announces $1.5bn Singapore manufacturing facility

(Sharecast News) - AstraZeneca announced plans to construct a $1.5bn manufacturing facility in Singapore on Monday, dedicated to the production of antibody drug conjugates (ADCs).

Read more
17 May 2024 22:25

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial

May 17 (Reuters) - AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent rights.

Read more
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.